Pulmonx Corp — Director's Dealing 2021

Jun 12, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Pulmonx Corp (LUNG)
CIK: 0001127537
Period of Report: 2021-06-01

Reporting Person: Rose Geoffrey Beran (Chief Commercial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-06-01	Common Stock	A	17600	$0.00	Acquired	180885	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-06-01	Employee Stock Option (right to buy)	$43.40	A	39900	Acquired	2031-05-31	Common Stock (39900)	Direct

Footnotes

F1: Represents grant of Restricted Stock Units payable solely in common stock of the Issuer that vest over four years in equal quarterly installments beginning on June 1, 2021.

F2: The shares subject to the option vest in 48 equal monthly installments beginning on June 1, 2021.